Statement of Ownership (sc 13g)
February 13 2020 - 1:47PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
COM
|
(Title of Class of Securities)
|
12/31/2019
|
(Date of Event Which Requires Filing of this Statement)
|
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures
provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the Notes).
1
|
NAMES OF REPORTING PERSONS
|
|
|
Schroder Investment Management Ltd.
|
|
|
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
|
(a)☐
|
|
|
(b)☐
|
|
|
3
|
SEC USE ONLY
|
|
|
|
|
|
|
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
United Kingdom
|
|
|
|
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
3,357,718
|
|
|
|
|
6
|
SHARED VOTING POWER
|
|
|
0
|
|
|
|
|
7
|
SOLE DISPOSITIVE POWER
|
|
|
3,357,718
|
|
|
|
|
8
|
SHARED DISPOSITIVE POWER
|
|
|
0
|
|
|
|
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
3,357,718
|
|
|
|
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
☐
|
|
|
|
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
7.173% of outstanding shares
|
|
|
|
|
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
IA
|
|
|
|
|
Item 1.
|
(b)
|
Address of Issuer’s Principal Executive Offices
12400 High Bluff Drive, Suite 600 San Diego, CA 92130
|
|
Item 2.
|
(b)
|
Address of Principal Business Office or, if none, Residence
7 Bryant Park, 19th Floor
New York, NY 10018
|
|
(d)
|
Title of Class of Securities
COM
|
|
(e)
|
CUSIP Number
30048L104
|
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.
Not applicable.
Not applicable.
Not applicable.
Schroder Investment Management Ltd., is a registered investment adviser with their respective home country regulator and under common control with the adviser. Schroder Investment Management Ltd is located in the United Kingdom at 1 London Wall
Place, London EC2Y 5AU.
Schroder Investment Management North America Inc. disclaims the existence of a group.
Not applicable.
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of
changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.
|
Name:
|
Marc Brookman**
|
|
Title:
|
Chief Executive Officer
|
|
|
|
|
Schroder Investment Management North America Inc
|
|
|
|
**Authorized by Power of Attorney to sign on behalf of the following Advisor:
Schroder Investment Management Ltd.
|
5
Evofem Biosciences (NASDAQ:EVFM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Evofem Biosciences (NASDAQ:EVFM)
Historical Stock Chart
From Sep 2023 to Sep 2024